Louise Kooij
Comptroller/Controller/Auditor at FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Net worth: - $ as of 30/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael Davidson | M | 67 | 2 years | |
Sander Slootweg | M | - | - | |
Janneke van der Kamp | F | 49 | 1 years | |
Bob Rambo | M | - | 1 years | |
James Jacobson | M | - | 2 years | |
Stefano Portolano | M | - |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | 3 years |
John Kastelein | M | 70 | 2 years | |
Juliette Audet | F | 38 | 2 years | |
John Smither | M | 71 | 1 years | |
Douglas Kling | M | 50 | 3 years | |
Louis Lange | M | 72 | 2 years | |
Nicholas Downing | M | 39 | 2 years | |
Marc Ditmarsch | M | 58 | 4 years | |
Will Lewis | M | 55 | - | |
Mayur Ian Somaiya | M | 50 | 1 years | |
Annie Neild | F | - | 3 years | |
Silvia Ragno | M | - |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | 1 years |
James Topper | M | 62 | 2 years | |
William Jones | M | 60 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Olivier Morand | M | - |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Azafaros BV develops therapeutic agents for the treatment of rare metabolic disorders. The company was founded on July 1, 2018 and is headquartered in Leiden, the Netherlands. | - |
Jennifer Chien | F | 49 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
Netherlands | 20 | 95.24% |
United Kingdom | 1 | 4.76% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Louise Kooij
- Personal Network